Patents by Inventor Wayne L. Cody

Wayne L. Cody has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Endothelin Antagonists II
    Patent number: 5550110
    Abstract: Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute and chronic renal failure, hypertension, myocardial infarction, metabolic, endocrinological, neurological disorders especially cerebral vasospasm, stroke, and head injury, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, preeclampsia, atherosclerotic disorders including Raynaud's disease, restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, hemorrhagic shock, ischemic bowel disease, and diabetes.
    Type: Grant
    Filed: June 30, 1994
    Date of Patent: August 27, 1996
    Assignee: Warner-Lambert Company
    Inventors: Wayne L. Cody, Annette M. Doherty, John G. Topliss
  • Polypeptide compounds having growth hormone releasing activity
    Patent number: 5534494
    Abstract: Disclosed are novel polypeptide compounds which promote the release and elevation of growth hormone levels in the blood of animals. Also disclosed are methods of promoting the release and elevation of growth hormone levels in the blood of animals using the disclosed polypeptide compounds.
    Type: Grant
    Filed: April 21, 1994
    Date of Patent: July 9, 1996
    Assignee: Polygen Holding Corporation
    Inventors: Cyril Y. Bowers, Frank A. Momany, Ching H. Chang, Wayne L. Cody, John C. Hubbs, Charles H. Foster
  • Polypeptide compounds having growth hormone releasing activity
    Patent number: 5486505
    Abstract: Novel polypeptides which promote the release of growth hormone when administered to animals are described. These polypeptides have the formula:A.sub.1 --D.sup..beta. Nal--A.sub.3 --Trp--A.sub.5 --A.sub.6 --Zwherein A.sub.1, A.sub.3, A.sub.5, A.sub.6 and Z" are as defined in the specification.
    Type: Grant
    Filed: October 16, 1992
    Date of Patent: January 23, 1996
    Assignee: Polygen Holding Corporation
    Inventors: Cyril Y. Bowers, Wayne L. Cody, John C. Hubbs, Charles H. Foster, Frank A. Momany
  • Endotherlin antagonists
    Patent number: 5382569
    Abstract: Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute and chronic renal failure, hypertension, myocardial infarction, metabolic, endocrinological, neurological disorders, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, preeclampsia, Raynaud's disease, percutaneous transluminal coronary angioplasty or restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, ischemic bowel disease, and diabetes.
    Type: Grant
    Filed: December 21, 1992
    Date of Patent: January 17, 1995
    Assignee: Warner-Lambert Company
    Inventors: Wayne L. Cody, Patricia DePue, Annette M. Doherty, John X. He, Michael D. Taylor
  • Linear and monocyclic endothelin antagonists
    Patent number: 5260276
    Abstract: Novel linear and monocyclic antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in controlling hypertension, myocardial infarction, metabolic, endocrinological, and neurological disorders, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, acute renal failure, preeclampsia, and diabetes.
    Type: Grant
    Filed: June 14, 1991
    Date of Patent: November 9, 1993
    Assignee: Warner-Lambert Company
    Inventors: Wayne L. Cody, Annette M. Doherty, John X. He
  • Composition for stimulating integumental melanocytes
    Patent number: 5049547
    Abstract: A pharmaceutically active composition comprising a pharmaceutically acceptable carrier and one or more alpha-MSH or analogues thereof for use in the stimulation of integumental melanocytes in vertebrates in order to bring about the production of melanin is disclosed.
    Type: Grant
    Filed: April 19, 1989
    Date of Patent: September 17, 1991
    Assignee: University Patents, Inc.
    Inventors: Victor J. Hruby, Mac E. Hadley, Robert Dorr, Norman Levine, Elizabeth Sugg, Wayne L. Cody
  • Method of stimulating integumental melanocytes by topical application of analogs of alpha-msh
    Patent number: 4866038
    Abstract: A method for stimulating integumental melanocytes by the topical application of alpha-MSH analogs, and compositions comprising said analogs for use in the method are described.
    Type: Grant
    Filed: July 22, 1988
    Date of Patent: September 12, 1989
    Assignee: University Patents, Inc.
    Inventors: Victor J. Hruby, Mac E. Hadley, Robert Dorr, Norman Levine, Elizabeth Sugg, Wayne L. Cody
  • Polypeptide compounds having growth hormone releasing activity
    Patent number: 4839344
    Abstract: Disclosed are novel polypeptide compounds which promote the release and elevation of growth hormone levels in the blood of animals. Also disclosed are methods of promoting the release and elevation of growth hormone levels in the blood of animals using the disclosed polypeptide compounds.
    Type: Grant
    Filed: June 12, 1987
    Date of Patent: June 13, 1989
    Assignee: Eastman Kodak Company
    Inventors: Cyril Y. Bowers, Frank A. Momany, Ching H. Chang, Wayne L. Cody, John C. Hubbs, Charles H. Foster